The Society of Interventional Radiology (SIR) announced the publication of a position statement that provides evidence-based ...

Siemens Healthineers announced it has received FDA clearance for six new systems in its Artis interventional imaging ...

HistoSonics announced it has submitted a de novo request to the FDA seeking authorization to expand the use of its Edison ...

Artivion, Inc., headquartered in suburban Atlanta, Georgia, will acquire Israel-based Endospan, a developer of solutions for the end ...

Stryker announced that it has completed the acquisition of Amplitude Vascular Systems, Inc. (AVS), which is developing a next-genera ...

Data from the PROMISE III trial suggest that chronic limb-threatening ischemia (CLTI) patients with no other treatment ...

Rapid Medical announced full results from the DISTALS randomized clinical trial demonstrating that the company’s Tigertriever ...

Cordis announced the launch in Japan of the Selution SLR percutaneous transluminal angioplasty (PTA) drug-eluting balloon ...

Solaris Endovascular, Inc. announced that the FDA has granted Breakthrough Device designation for its Solaris DE drug-eluting ...

April 29, 2026—enVVeno Medical Corporation announced it has received an FDA investigational device exemption (IDE) for the pivotal study of the ...

In the CARPOOL study, radial-to-peripheral (R2P) access achieved procedural success rates comparable to traditional common ...

A comparative analysis from the ENGULF trial demonstrated that using blood return during continuous aspiration thrombectomy ...